Colon specific CODES based Piroxicam tablet for colon targeting: statistical optimization, in vivo roentgenography and stability assessment

References

• Henry CJ, McCaw DL, Turnquist SE, et al. Clinical evaluation of mitoxantrone and Piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 2003;9:1–8
   PubMed Web of Science ®Google Scholar
• Vats A, Pathak K. Tabletted guar gum microspheres of piroxicam for targeted adjuvant therapy for colonic adenocarcinomas. Ther Del 2012;3:1281–1295
   PubMedGoogle Scholar
• Sherratt PJ, McLellan LI, Hayes JD. Positive and negative regulation of prostaglandin E2 biosynthesis in human colorectal carcinoma cells by cancer chemopreventive agents. Biochem Pharmacol 2003;66:51–61
   PubMed Web of Science ®Google Scholar
• Pereira MA, Barnes LH, Steele VE, et al. Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats. Carcinogenesis 1996;17:373–376
   PubMed Web of Science ®Google Scholar
• Earnet DL, Hixon LJ, Albert DS. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J Cell Biochem 1992;50:156–166
   Google Scholar
• Calaluce R, Earnest DL, Heddens D, et al. Effect of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial. Cancer Epidemiol Biomarkers Prev 2000;9:1287–1292
   PubMed Web of Science ®Google Scholar
• Bandari S, Sanka K, Jukanti R, Veerareddy PR. Formulation and in vitro evaluation of pulsatile colon drug delivery system of piroxicam using 32 factorial design. Der Pharmacia Lettre 2010;2:177–188
   Google Scholar
• Challa A, Rao DR, Chawan CB, Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane induced colonic aberrant crypt foci in rats. Carcinogenesis 1997;18:517–521
   PubMed Web of Science ®Google Scholar
• van Berge Henegouwen GP, van der Werf SD, Ruben AT. Effect of long term lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colon carcinogenesis. Gut 1987;28:675–680
   PubMed Web of Science ®Google Scholar
• Yang L, Chu JS, Fix JA. Colon specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 2002;235:1–15
   PubMed Web of Science ®Google Scholar
• Li J, Yang L, Ferguson SM, et al. In vitro evaluation of dissolution behaviour for a colon-specific drug delivery system (CODES™) in multi-pH media using United States Pharmacopeia Apparatus II and III. AAPS PharmSciTech 2002;3:Article 33
   Google Scholar
• Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. Int J Pharm 2012;427:153–162
   PubMed Web of Science ®Google Scholar
• Indian Pharmacopoeia. Vol. 1. New Delhi: Government of India, Ministry of Health & Family Welfare, Controller of Publication; 2007:179–200
   Google Scholar
• United States Pharmacopoeia 30-NF 25. Rockville: Asian Ed., United States Pharmacopoeial Convention Inc.; 2007:1216
   Google Scholar
• Dev RK, Bali V, Pathak K. Novel microbially triggered colon specific delivery system of 5-fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessments. Int J Pharm 2011;411:142–151
   PubMed Web of Science ®Google Scholar
• Karatas A, Yuksel N, Baykara T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. IL Pharmacol 2005;60:777–782
   Google Scholar
• Mirza S, Miroshnyk I, Habib MJ, et al. Enhanced dissolution and oral bioavailability of piroxicam formulation: modulating effect of phospholipid. Pharmaceutics 2010;2:339–350
   PubMedGoogle Scholar
• Lahdenpaa E, Niskanen M, Yliruusi J. Crushing strength, disintegration time and weight variation of tablets compressed from three avicel PH grades and their mixtures. Eur J Pharm Biopharm 1997;43:315–322
   Web of Science ®Google Scholar
• Zhang Y, Law Y, Chakrabarti S. Physical properties and compact analysis of commonly use direct compression binders. AAPS PharmSciTech 2003;4:489–499
   Google Scholar
• Shaikh MS. Double coated tablets of nimesulide for colon targeting. Int J Pharm Sci Nanotech 2010;3:1000–1005
   Google Scholar
• Meghal AK, Chaudari PS, Mathur VB. Formulation and evaluation of enteric coated HPMC capsule of diclofenac sodium. RJPBCS 2011;2:790–798
   Google Scholar
• Maestrelli F, Zerrouk N, Cirri M, et al. Microspheres for colonic delivery of ketoprofen – hydroxypropyl-β- cyclodextrin complex. Eur J Pharm Sci 2008;34:1–11
   PubMed Web of Science ®Google Scholar
• Joshi M. Role of Eudragit in targeted drug delivery. Int J Curr Pharma Res 2013;5:58--62
   Google Scholar
• Sharma P, Pathak K. Inulin based tablet in capsule device for variable multiple delivery of aceclofenac: optimization and in vivo roentgenography. AAPS PharmSci Tech 2013;14:736–747
   PubMed Web of Science ®Google Scholar
• Sahota SS, Bramley PM, Menzies IS. The fermentation of lactulose by colonic bacteria. J Gen Microbiol 1982;128:319–325
   PubMedGoogle Scholar
• Afsar B, Elsurer R, Bilgic A, et al. Regular lactulose use is associated with lower peritonitis rates: an observational study. Perit Dial Int 2010;30:243–246
   PubMed Web of Science ®Google Scholar
• Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Ailment Pharmacol Ther 2008;28:385–396
   PubMed Web of Science ®Google Scholar
• Florey K. Analytical profiles of drug substances. In: Mihalic M, Hofman H, Kuftinec J, et al., eds. Piroxicam. Vol. 15. New Jersy: Academic Press; 2005:509–520
   Google Scholar
• Patel RP, Patel DJ, Bhimani DB, Patel JK. Physicochemical characterization and dissolution study of solid dispersion of furesomide with poly ethylene glycol 6000 and polyvinylpyrrolidone K30. Diss Technol 2008;3:17–28
   Google Scholar
• Gidenne T, Lebs F. Feeding behaviour in rabbits. In: Bels V, ed. Feeding in domestic vertebrates from structure to behaviour. Oxfordshire: CABI Publishing; 2006:179–194
   Google Scholar
• Davies RR, Davies JAER. Rabbit gastrointestinal physiology. Vet Clin Exot Anim 2003;6:139–153
   PubMedGoogle Scholar
• Ghosh MN. Fundamentals of experimental pharmacology. Kolkata: Hilton and Company; 2008
   Google Scholar
• Patel MM, Amin AF. Design and optimization of colon targeted system of theophylline for chronotherapy of nocturnal asthma. J Pharm Sci 2011;100:1760–1772
   PubMed Web of Science ®Google Scholar
• Patel MM, Amin AF. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. Drug Deliv 2011;18:281–293
   PubMed Web of Science ®Google Scholar
• Gohel MC, Sarvaiya KG, Mehta NR, et al. Assessment of similarity factor using different weighting approaches. Diss Technol 2005;12:22–37
   Google Scholar